Digital medicines systems such as EPS, ePMA and Prescription Tracking Services (PTS) have delivered significant benefits in supporting safer, more efficient and more consistent medicines pathways. However, as with any digital transformation, they can also introduce new clinical risks that require structured safety assessment and governance. Although digital clinical safety has long been an established NHS requirement, levels of familiarity with safety cases, hazard analysis and the Clinical Safety Officer (CSO) role can vary across pharmacy teams.
This session provides a clear and practical introduction to clinical risk management for digital pharmacy technologies, explaining the purpose of national safety standards (DCB0129/0160), how safety cases are developed and what the CSO contributes to safe system deployment. Using two real world NHS examples — 1) implementing EPS and 2) integrating ePMA with a Prescription Tracking Service (PTS)

• Practical understanding of NHS digital clinical safety standards; Identify and assess clinical hazards in digital pharmacy workflows
• Build confidence to contribute to clinical safety governance and assurance
• Applied learning from real digital pharmacy implementations